Richards, D. Prevalence and clinical course of depression: a review. Clin Psychol Rev
2011; 31: 1117–25.
Kaymaz, N, van Os, J, Loonen, AJ, Nolen, WA. Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry
2008; 69: 1423–36.
Borges, S, Chen, YF, Laughren, TP, Temple, R, Patel, HD, David, PA, et al. Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration. J Clin Psychiatry
2014; 75: 205–14.
Viguera, AC, Baldessarini, RJ, Friedberg, J. Discontinuing antidepressant treatment in major depression. Harv Rev Psychiatry
1998; 5: 293–306.
American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder, 3rd edn. APA, 2010.
National Institute for Health and Care Excellence. Depression in Adults: The Treatment and Management of Depression in Adults (CG90).
National Institute for Health and Care Excellence, 2009.
Bockting, CL, ten Doesschate, MC, Spijker, J, Spinhoven, P, Koeter, MW, Schene, AH. Continuation and maintenance use of antidepressants in recurrent depression. Psychother Psychosom
2008; 77: 17–26.
Dobson, KS, Hollon, SD, Dimidjian, S, Schmaling, KB, Kohlenberg, RJ, Gallop, RJ, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. J Consult Clin Psychol
2008; 76: 468–77.
van Schaik, D, Klijn, A, van Hout, H, van Marwijk, H, Beekman, A, de Haan, M, et al. Patients' preferences in the treatment of depressive disorder in primary care. Gen Hosp Psychiat
2004; 26: 184–9.
Segal, ZV, Williams, JMG, Teasdale, JD. Mindfulness-Based Cognitive Therapy for Depression, 2nd edn.
Guilford Press, 2012.
Kabat-Zinn, J. Full Catastrophe Living: Using the Wisdom of your Body and Mind to Face Stress, Pain, and Illness. Bantam Books, 2013.
Beck, AT, Rush, AJ, Shaw, BF, Emery, G. Cognitive Therapy of Depression.
Guilford Press, 1979.
Piet, J, Hougaard, E. The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis. Clin Psychol Rev
2011; 31: 1032–40.
Spijker, J, Bockting, CLH, Meeuwissen, JAC, Vliet, IM van, Emmelkamp, PMG, Hermens, MLM, et al. Multidisciplinaire Richtlijn Depressie (Derde Revisie). Richtlijn voor de Diagnostiek, Behandeling en Begeleiding Van Volwassen Patiënten met een Depressieve Stoornis [Multidisciplinary Guidelines Depression (3rd revision). Guidelines for the Diagnosis, Treatment and Monitoring of Patients with Depressive Disorder].
Kuyken, W, Byford, S, Taylor, RS, Watkins, E, Holden, E, White, K, et al. Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. J Consult Clin Psychol
2008; 76: 966–78.
Segal, ZV, Bieling, P, Young, T, MacQueen, G, Cooke, R, Martin, L, et al. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression. Arch Gen Psychiatry
2010; 67: 1256–64.
Kuyken, W, Hayes, R, Barrett, B, Byng, R, Dalgleish, T, Kessler, D, et al. Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. Lancet
2015; 386: 63–73.
Huijbers, MJ, Spijker, J, Donders, AR, van Schaik, DJ, van Oppen, P, Ruhe, HG, et al. Preventing relapse in recurrent depression using mindfulness-based cognitive therapy, antidepressant medication or the combination: trial design and protocol of the MOMENT study. BMC Psychiatry
2012; 12: 125.
Huijbers, MJ, Spinhoven, P, Spijker, J, Ruhe, HG, van Schaik, DJ, van Oppen, P, et al. Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder. Randomised controlled trial. J Affect Disord
2015; 187: 54–61.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn, revised) (DSM-IV-TR). APA, 2000.
First, MB, Gibbon, M, Spitzer, RL, Williams, JBW. User Guide for the Structured Clinical Interview for DSM-IV Axis 1 Disorders. American Psychiatric Association, 1996.
Akkerhuis, GW. Vertaling IDS. H.C. Rümke Groep, 1997.
Rush, AJ, Gullion, CM, Basco, MR, Jarrett, RB, Trivedi, MH. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med
1996; 26: 477–86.
Segal, ZV, Williams, JMG, Teasdale, JD. Mindfulness-Based Cognitive Therapy for Depression: A New Approach to Relapse Prevention. Guilford Press, 2002.
Crane, RS, Eames, C, Kuyken, W, Hastings, RP, Williams, JMG, Bartley, T, et al. Development and validation of the mindfulness-based interventions–teaching assessment criteria (MBI:TAC). Assessment
2013; 20: 681–8.
Teasdale, JD, Segal, ZV, Williams, JMG, Ridgeway, VA, Soulsby, JM, Lau, MA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol
2000; 68: 615–23.
Landis, JR, Koch, GG. The measurement of observer agreement for categorical data. Biometrics
1977; 33: 159–74.
Trivedi, MH, Rush, AJ, Ibrahim, HM, Carmody, TJ, Biggs, MM, Suppes, T, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med
2004; 34: 73–82.
The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med
1998; 28: 551–8.
EMA Committee for Proprietary Medicinal Products. Points to consider on switching between superiority and non-inferiority. Br J Clin Pharmacol
2001; 52: 223.
Hardeveld, F, Spijker, J, De Graaf, R, Nolen, WA, Beekman, AT. Prevalence and predictors of recurrence of major depressive disorder in the adult population. Acta Psychiatr Scand
2010; 122: 184–91.
Cuijpers, P, Sijbrandij, M, Koole, SL, Andersson, G, Beekman, AT, Reynolds, CF. Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. World Psychiatry
2014; 13: 56–67.
Guidi, J, Fava, GA, Fava, M, Papakostas, GI. Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysis. Psychol Med
2011; 41: 321–31.
Fava, GA, Ruini, C, Rafanelli, C, Finos, L, Conti, S, Grandi, S. Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry
2004; 161: 1872–6.
Haddad, PM, Anderson, IM. Recognising and managing antidepressant discontinuation symptoms. Adv Psychiatr Treat
2007; 13: 447–57.
Lejoyeux, M, Ades, J. Antidepressant discontinuation: a review of the literature. J Clin Psychiatry
1997; 58 (suppl 7): 11–5.
Rosenbaum, JF, Fava, M, Hoog, SL, Ascroft, RC, Krebs, WB. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry
1998; 44: 77–87.
Verbeek-Heida, PM, Mathot, EF. Better safe than sorry—why patients prefer to stop using selective serotonin reuptake inhibitor (SSRI) antidepressants but are afraid to do so: results of a qualitative study. Chronic Illn
2006; 2: 133–42.
Goldberg, D. Plato versus Aristotle: categorical and dimensional models for common mental disorders. Compr Psychiatry
2000; 41: 8–13.
Kraemer, HC, Noda, A, O'Hara, R. Categorical versus dimensional approaches to diagnosis: methodological challenges. J Psychiatr Res
2004; 38: 17–25.